Clinical Trial Update: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating three doses of MDMA-assisted therapy for veterans with posttraumatic stress disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA-assisted therapy (3,4-methylenedioxymethamphetamine (MDMA) with psychotherapy)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2022-02-02